DUSSELDORF, Germany, May 3, 2023 /PRNewswire/ LenioBio GmbH, the Düsseldorf-based cell-free protein expression company, has announced that its founder and CEO, Dr. Remberto Martis, will be
QurieGen is a new spin-off of Radboud University that supports pharmaceutical companies in the early identification of successful drug molecules. This will have a major impact on the drug development process as it will enable rapid decision-making du
/PRNewswire/ LenioBio GmbH today announced it had achieved a key milestone for the company with the successful linear scaling of its cell-free protein.